PUBLIC COMPANY
saveSpringWorks Therapeutics Inc
updated 3mo ago
community read0 votes
pipeline
5
marketed
2
phase 3
0
catalysts ytd
1
approvals ytd
1
recalls ytd
0
Pipeline(5)
pipeline depth5 products
1Phase 11Phase 22Marketed1Unknown
Marketed
mirdametinib ODT
Neurofibromatoses Type I (Von Recklinghausen's Disease)
Marketednirogacestat hydrobromide
Desmoid Tumors
Phase 2mirdametinib
Non-Small Cell Lung Cancer
Dual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2
Phase 1SW-682
Malignant Mesothelioma
drugOGSIVEO
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Milestone cutting 20% of HQ team, including CMOFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 20h ago
- Merck KGaA makes noise in hematology with $1.1B Silence buySilence Therapeutics’ lead siRNA asset for the rare blood cancer polycythemia vera has been earning analyst raves in a tight race to challenge Takeda in a potential $2 billion market.biospace · 25d ago
- Merck KGaA bets on RNAi with $1.3B Silence buyoutThe acquisition gives the German company a promising blood disorder medicine that passed a Phase 2 test and could threaten a Takeda drug.biopharma_dive · 25d ago
- Merck KGaA buys Silence in $1.3B deal after siRNA drug's phase 2 blood cancer winGermany’s Merck KGaA has picked up Silence Therapeutics to the tune of $1.3 billion in the wake of the British biotech’s mid-stage success for its challenger to Takeda’s Mimrylo.fiercebiotech · 26d ago
- Beeline flies into phase 3 as oral lupus drug soars past placeboA phase 2 trial of Beeline Medicines’ afimetoran has hit its primary endpoint, positioning the biotech to swarm into pivotal development in two forms of lupus.fiercebiotech · 2mo ago
- Beeline ups its Series A round for immune drug workThe company, which was built by Bain Capital, has now raised more than $426 million in its quest to advance a portfolio of Bristol Myers drugs.biopharma_dive · 4mo ago
- Fierce Biotech Layoff Tracker 2026: Milestone shrinks HQ workforce during Cardamyst rolloutAs always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.fiercebiotech · 10mo ago
- Fierce Biotech Fundraising Tracker '26: China's Eli Radiopharma raises $60M; Neurosterix notches $105MThe Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.fiercebiotech · 10mo ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that